Abstract
Hypertension is the leading cause of cardiovascular diseases and nephropathies. Its treatment and management require long term follow-up which can be facilitated by the emergence of device-based therapies. Novel recommendations have been well described in the latest ESH guidelines as well as new risk factors have been identified. We summarized the published evidence on hypertension management. We also cited in this review novel treatment approaches in different settings and the intervention of medication adherence in treatment success. Such non communicable disease requires long-term follow up and monitoring which is quite facilitated in the era of digitalization by cuff-less based devices based on prediction tools.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
